期刊文献+

二氟沙星肺靶向微球制剂的制备 被引量:3

Preparation for lung targeted microsphere of Difloxacin
下载PDF
导出
摘要 以可生物降解的明胶为载体,液体石蜡为油相,Span-80为乳化剂,选择正交设计优化空白明胶微球生产工艺,并考察其理化性质,采用乳化交联法制备二氟沙星肺靶向明胶微球。采用紫外可见分光光度计法,测定微球中二氟沙星的含量。结果表明,优选所制的二氟沙星肺靶向明胶微球形态圆整,表面光滑,平均粒径为8.33μm,粒径分布在5.0~25.0μm的微球达到95.71%,二氟沙星明胶微球包封率为62.43%,载药量为13.71%。采用动态分析法研究体外释药特性,二氟沙星明胶微球在12h处药物释放量达到65%,24h内药物释放量达到71%。制备工艺稳定可行,所得二氟沙星明胶微球具有良好的缓释效果。 The preparation technology was optimized by orthogonal experimental designed with biodegradable gelatin as the carrier, liquid paraffin as the oilphase, span-80 as the emulsifier, and Difloxacin loaded gelatin microsphere for lung targetting was prepared by the emulsion crosslinking method. Quantitative determination of Difloxacin was carried on by the method of UV spectrophotometry. and the optimal Difloxacin loaded gelatin microsphere was global with smooth surface, The arithmetic mean diameter of microsphere was 8.33 μm with 95.71% of microsphere which are ranging from 5.0 to 25.0 μm, total 62.43% for the encapsulation efficiency, and 13.71% for the drug loading, The release test in vitro showed that 65% of Difioxacin could release from gelatin microsphere in 12 h and 71% in 24 h with dynamic analysis. The preparation technology is good and stable, and the obtained microsphere can control the release of Difloxacin.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2009年第12期83-86,共4页 Journal of Northeast Agricultural University
基金 东北农业大学大学生科技创新基金
关键词 二氟沙星 肺靶向 明胶微球 Difloxacin lung targetting gelatin microsphere
  • 相关文献

参考文献6

二级参考文献21

  • 1Hoven R. A multi-centre observational study on the efficacy of dicural palatabs(difloxacin) for the treatment of canine cystitis[J].Journal of Veterinary Pharmacology &Therapeutics, 1997,20(suppl1):181~218.
  • 2Timothy W J, Olchowy D V M phD.Efficacy of difloxacin in calves experimentally infected with Mannheimia haemolytica[J].American Journal of Veterinary Research, 2000,61(6):710~713.
  • 3Frazier D L,Thompson I,et al. Comparison of fluoroquinolone pharmacokinetic parameters after creatment with marbofloxacin,enrofloxacin,and difloxacin in dogs [J]. Journal of VeterinarPharmacology & Therapeutics, 2003,23(5):293~302.
  • 4Heinen E.Comparative pharmacokinetics of enrofloxacin and difloxacin as w ell as their main metabolites in dogs[J].Compendium on Continuing Education for the Practicing Veterinarian, 1999,(suppl 21),12~18.
  • 5Burkhardt J E, Hill M A. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin,a fluoroquinolone[J]. Veterinary Pathology,2003,29(3) :230~238.
  • 6Roybal J E ,Phenning A P ,Turnipseed S B ,et al .Determination of four fouoroquinolones in milk liquid chromatography [J].AOAC Int .1997,80(5):982~987.
  • 7Dijkstra J W.A total residue depletion and metabolism study with 14C-difloxacin in chickens and turkeys [J]. Journal of Veterinary Pharmacology &Therapeutics, 1997,20(suppl 1):294~317.
  • 8Park TG,Lu WQ,Crotts G.Importance of in vitro experimental conditions on protein release kinetics,stability and polymer degradation in protein encapsulated poly(D,L-lacitic-co-glycolic acid)microspheres[J].J Controlled Release,1995,33(22):211-222.
  • 9刘明亮.喹诺酮类抗菌药的结构特征及构效关系[J].国外医药(抗生素分册),1999,20(3):116-120. 被引量:9
  • 10孙永祥,阎明珠,张明,刘再胜.盐酸二氟沙星粉治疗鸡大肠杆菌病临床试验[J].辽宁畜牧兽医,1999(3):27-28. 被引量:5

共引文献40

同被引文献57

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部